Published in World J Gastroenterol on February 28, 2014
Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances. World J Gastroenterol (2016) 0.87
American Cancer Society Colorectal Cancer Survivorship Care Guidelines. CA Cancer J Clin (2015) 0.86
Optimal delivery of colorectal cancer follow-up care: improving patient outcomes. Patient Relat Outcome Meas (2015) 0.79
Colonoscopy Surveillance after Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2016) 0.76
Surveillance after curative treatment for colorectal cancer. Nat Rev Clin Oncol (2016) 0.75
Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations. Clin Med Insights Oncol (2017) 0.75
Surgery along the embryological planes for colon cancer: a systematic review of complete mesocolic excision. Int J Colorectal Dis (2016) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Colorectal cancer. Lancet (2010) 8.36
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut (2010) 6.34
A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut (2004) 5.97
Cost-effectiveness of screening for colorectal cancer in the general population. JAMA (2000) 5.88
Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 5.76
Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA (2014) 5.50
Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med (2006) 5.10
Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology (1998) 4.58
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2005) 4.10
Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst (2010) 3.05
Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. J Clin Oncol (2011) 2.55
Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol (2005) 2.48
Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev (2007) 2.27
Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum (1988) 2.20
Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg (1995) 2.17
The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res (1999) 1.98
A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg (1997) 1.87
Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum (2007) 1.85
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set. J Clin Oncol (2008) 1.82
Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum (1998) 1.76
Receipt of guideline-recommended follow-up in older colorectal cancer survivors : a population-based analysis. Cancer (2008) 1.74
Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum (1995) 1.72
General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer (2006) 1.68
The cost-effectiveness of screening for colorectal cancer. CMAJ (2010) 1.67
Preoperative staging with chest CT in patients with colorectal carcinoma: not as a routine procedure. Ann Surg Oncol (2010) 1.64
Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol (2002) 1.55
Is intensive follow-up really able to improve prognosis of patients with local recurrence after curative surgery for rectal cancer? Ann Surg Oncol (2000) 1.55
Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum (2005) 1.52
Colorectal cancer follow-up: perspectives for future studies. Eur J Surg Oncol (2000) 1.47
Hepatic resection for isolated metastasis from colorectal carcinoma. Am J Surg (1985) 1.46
Nurse or surgeon follow-up after rectal cancer: a randomized trial. Colorectal Dis (2010) 1.44
Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ (2004) 1.41
Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer (1997) 1.40
Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581. J Clin Oncol (2013) 1.27
Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum (2004) 1.26
Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis. Ann Intern Med (2010) 1.24
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. Ann Oncol (2008) 1.24
Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol (1999) 1.20
Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial. Surg Oncol (2004) 1.14
Should indeterminate lung lesions reported on staging CT scans influence the management of patients with colorectal cancer? Colorectal Dis (2007) 1.07
Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dis Colon Rectum (1993) 1.07
Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis. Br J Cancer (2005) 1.05
Surveillance endoscopy does not improve survival for patients with local and regional stage colorectal cancer. Cancer (2007) 1.02
Results of long-term follow-up after curative resection of Dukes A colorectal cancer. World J Surg (2002) 1.02
Surveillance after colorectal cancer resection: a systematic review. Dis Colon Rectum (2011) 1.01
Estimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation. Med Decis Making (2011) 1.00
Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study. Ann Surg (2012) 0.99
The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests. Int J Colorectal Dis (1997) 0.97
Time to locoregional recurrence after curative resection of rectal carcinoma is prolonged after neoadjuvant treatment: a systematic review and meta-analysis. Colorectal Dis (2011) 0.96
An interim analysis of recruitment to the COLOFOL trial. Colorectal Dis (2009) 0.93
Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis. Ann Surg (2003) 0.93
Receipt of recommended surveillance among colorectal cancer survivors: a systematic review. J Cancer Surviv (2013) 0.92
Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery. Clin Oncol (R Coll Radiol) (2010) 0.90
Hepatic resection for metastatic disease. Can J Surg (1986) 0.90
Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol (2012) 0.88
A multigene prognostic assay for selection of adjuvant chemotherapy in patients with T3, stage II colon cancer: impact on quality-adjusted life expectancy and costs. Value Health (2012) 0.87
Surveillance of patients following surgery with curative intent for colorectal cancer. World J Gastroenterol (2007) 0.85
Endoscopic surveillance after curative surgery for sporadic colorectal cancer: patient-tailored, tumor-targeted or biology-driven? Scand J Gastroenterol (2010) 0.84
Routine compared with nonscheduled follow-up of patients with "curative" surgery for colorectal cancer. Ann Surg Oncol (1996) 0.83
Choice of surveillance after hepatectomy for colorectal metastases. Arch Surg (2004) 0.83
An unsolved conundrum: the ideal follow-up strategy after curative surgery for colorectal cancer. Gastrointest Endosc (2012) 0.82
Improved local control of rectal cancer reduces distant metastases. Colorectal Dis (2012) 0.82
Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model. World J Surg (2004) 0.81
Improving colorectal cancer follow-up: the dedicated single-visit colorectal cancer follow-up clinic. Ann R Coll Surg Engl (2002) 0.80
Follow-up in colorectal cancer: questions to be answered. Colorectal Dis (2011) 0.79
Colorectal cancer: A rational follow-up program adapted to patient's individual risk of recurrence and review of the literature. Eur J Med Res (1999) 0.78